The Advancing Discovery Summit series is a concentrated effort to bring stakeholders from many sectors together to address a very challenging issue. Many medications for mental illnesses have significant side effects ranging from weight gain to movement disorders like tardive dyskinesia—but very few new medications are being developed. NAMI strives to empower our members to advocate for more funding and support for the scientific research that will lead to better therapies. With our partners in brain research, genetic research, pharmaceutical development, and policy—and with your support—we can advance this goal.

Readings and Resources

Working Together to Advance Discovery and Reignite Hope – a white paper co-authored by NAMI's Dr. Ken Duckworth, Dr. Teri Brister and Elizabeth Stafford, along with the Broad Institute's Dr. Rosy Hosking placing the Advancing Discovery Summit's exciting work in an important historical context.

Time for New Schizophrenia Rx – a compelling editorial from Dr. Steve Hyman, Director of the Stanley Center for Psychiatric Research, which provided the initial motivation for the Advancing Discovery Summit.

Javascript must be enabled for the correct page displayJavascript must be enabled for the correct page displayJavascript must be enabled for the correct page displayJavascript must be enabled for the correct page display